The EDC is live today — see what ships now
All studies
NCT07019714From ClinicalTrials.govRecruiting

Daoyin Technique for Improving Exercise Endurance in IPF

Clinical Research on the Improvement of Exercise Endurance in Idiopathic Pulmonary Fibrosis by Daoyin Technique

  • Idiopathic Pulmonary Fibrosis

At a glance

Phase
Phase not stated
Study type
Interventional
Sponsor
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Enrolment target
236
Started
22 April 2026
Main results due
30 May 2028
Study sites
3
Registry updated
29 September 2026

Can you take part?

  • Ages 40 years to 85 years.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

1. Patients who meet the diagnostic criteria for IPF;
2. Those who can tolerate guided - technique training;
3. Aged between 40 and 85 years old;
4. Those who can independently or with the assistance of family members use devices such as smartphones and computers during home - based training;
5. Those who voluntarily accept treatment and sign the informed consent form.

Exclusion Criteria:

1. Patients in the acute exacerbation phase of IPF.
2. Patients with comorbidities such as chronic obstructive pulmonary disease, lung cancer, active pulmonary tuberculosis, bronchiectasis, pulmonary embolism, and other pulmonary diseases.
3. Patients with severe cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina pectoris, acute myocardial infarction, cardiac function at grade 3 or above, stroke, cerebral hemorrhage, etc.).
4. Patients with severe liver diseases (such as bleeding caused by liver cirrhosis, portal hypertension, and esophagogastric varices) and severe kidney diseases (dialysis, kidney transplantation, etc.).
5. Patients with severe osteoarthropathy or osteoporosis, and those with unstable fractures.
6. Patients with progressive neuromuscular diseases.
7. Patients with unclear consciousness, dementia, and various mental illnesses.
8. Pregnant or lactating women, and patients with a recent pregnancy plan.
9. Patients who have been participating in other clinical trials within 1 month before enrollment.
10. Patients who need long - term use of ventilators and those with unstable vital signs while bedridden.

What this study is about

In the sponsor’s own words, from the registry.

This study is based on the previously constructed digital rehabilitation management platform, scientifically evaluating the clinical efficacy of guided technology in improving IPF exercise endurance, and forming high-quality clinical evidence.

Study sites(3)

  • Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Beijing, Beijing Municipality, China

    Recruiting

  • The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

    Zhengzhou, Henan, China

    Recruiting

  • The Affiliated Hospital of Liaoning University of Traditional Chinese Medicinenese Medicine

    Shenyang, Liaoning, China

    Recruiting

Showing 3 of 3 sites. 3 of the 3 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07019714. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
Daoyin Technique for Improving Exercise Endurance in IPF | Trialion